Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of diabetes and cardiovascular outcomes in high-risk prediabetes
IRCT20211118053095N1Phase 3Recruiting
- Sponsor
- Ministry of Health and Medical Education
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metformin in prediabetes (2 arms), sponsored by Ministry of Health and Medical Education. Primary endpoints: Diabetes mellitus, Cardiovascular diseases and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on IRCT20211118053095N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211118053095N1.